Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients-Reference-Cited by-同舟云学术

Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients

Published:2021-03 Issue: Volume:Volume 15 Page:1195-1211
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Kalam Muhammad Nasir,Rasool Muhammad Fawad^ORCID,Alqahtani Faleh^ORCID,Imran Imran,Rehman Asim Ur,Ahmed Naveed^ORCID

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference74 articles.

1. Clinical Pharmacokinetics of Propranolol Hydrochloride: A Review

2. Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension

3. Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis

4. Chinese guidelines on the management of ascites and its related complications in cirrhosis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically Based Pharmacokinetic Model for Predicting Omadacycline Pharmacokinetics and Pharmacodynamics in Healthy and Hepatic Impairment Populations;Clinical Therapeutics;2024-08

2. A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment;Pharmaceuticals;2024-07-10

3. Investigating clinical pharmacokinetics of brivaracetam by using a pharmacokinetic modeling approach;Scientific Reports;2024-06-11

4. Physiologically Based Pharmacokinetic Modeling of Lacosamide in Patients With Hepatic and Renal Impairment and Pediatric Populations to Support Pediatric Dosing Optimization;Clinical Therapeutics;2024-03

5. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions;British Journal of Clinical Pharmacology;2024-01-25